Doctors test Direct-Abdominal treatment for tough stomach cancer
NCT ID NCT07454031
Summary
This early-stage study is testing whether a new combination of two drugs, delivered directly into the abdomen, is safe and tolerable for patients with a specific type of advanced stomach cancer that has spread to the abdominal lining. The main goal is to find the highest dose patients can handle without severe side effects. Researchers will enroll about 22 adults with this condition to carefully monitor how their bodies respond.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL (METASTATIC) CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.